Enlaza Therapeutics

Enlaza Therapeutics

Biotechnology, 2400 Market St, San Diego, California, 19103, United States, 11-50 Employees

enlazatx.com

  • LinkedIn

phone no Phone Number: +12*********

Who is ENLAZA THERAPEUTICS

Enlaza Therapeutics is pioneering the field of covalent biologics. These novel classes of protein therapeutics deliver more efficacious and safer treatments for patients. The companys pro...

Read More

map
  • 2400 Market St, San Diego, California, 19103, United States Headquarters: 2400 Market St, San Diego, California, 19103, United States
  • 1939 Date Founded: 1939
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Billion and Over
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 5812

checked-icon Does something look wrong? Fix it. | View contact records from ENLAZA THERAPEUTICS

Enlaza Therapeutics Org Chart and Mapping

Employees

Jiao Ma

Principal Scientist

Ashley Vieira

Sra/Associate Scientist, in Vivo Pharmacology

Miguel Galvan

Senior Research Associate, Drug Discovery

Katie Schierenbeck

Associate Scientist, Pharmacology & Translational Research

Jannalyn Rogers

Senior Research Associate

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Enlaza Therapeutics

Answer: Enlaza Therapeutics's headquarters are located at 2400 Market St, San Diego, California, 19103, United States

Answer: Enlaza Therapeutics's phone number is +12*********

Answer: Enlaza Therapeutics's official website is https://enlazatx.com

Answer: Enlaza Therapeutics's revenue is $1 Billion and Over

Answer: Enlaza Therapeutics's SIC: 5812

Answer: Enlaza Therapeutics has 11-50 employees

Answer: Enlaza Therapeutics is in Biotechnology

Answer: Enlaza Therapeutics contact info: Phone number: +12********* Website: https://enlazatx.com

Answer: Enlaza Therapeutics is pioneering the field of covalent biologics. These novel classes of protein therapeutics deliver more efficacious and safer treatments for patients. The companys proprietary War-LockTM platform leverages leading synthetic biology technology for site-specific covalent coupling driven by drug binding. Enlaza is building a pipeline of first-in-class covalent biologics.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access